Found this and it was too informative not to post. Page 19 shows three years from SPA to NDA even without QIDP granted prior to SPA. So Brilacidin should reach approval faster.

Plenty of other good reference statistics for comparison as well.

http://www.fda.gov/downloads/AdvisoryCommitte...392561.pdf